Patents by Inventor Galina N. Filippova

Galina N. Filippova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140141439
    Abstract: The present invention provides compositions and methods of identifying a subject as having an increased risk of developing fragile X-associated tremor and ataxia syndrome (FXTAS) or identifying a subject having an increased risk of developing fragile X syndrome (FXS), comprising analyzing messenger RNA (mRNA) transcripts and/or translation products of the antisense gene ASFMR1.
    Type: Application
    Filed: October 31, 2013
    Publication date: May 22, 2014
    Applicant: THE FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventors: STEPHEN J. TAPSCOTT, GALINA N. FILIPPOVA, PAULA D. LADD
  • Patent number: 8597880
    Abstract: The present invention provides compositions and methods of identifying a subject as having an increased risk of developing fragile X-associated tremor and ataxia syndrome (FXTAS) or identifying a subject having an increased risk of developing fragile X syndrome (FXS), comprising analyzing messenger RNA (mRNA) transcripts and/or translation products of the antisense gene ASFMR1.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: December 3, 2013
    Assignee: The Fred Hutchinson Cancer Research Center
    Inventors: Stephen J. Tapscott, Galina N. Filippova, Paula D. Ladd
  • Publication number: 20100279293
    Abstract: The present invention provides compositions and methods of identifying a subject as having an increased risk of developing fragile X-associated tremor and ataxia syndrome (FXTAS) or identifying a subject having an increased risk of developing fragile X syndrome (FXS), comprising analyzing messenger RNA (mRNA) transcripts and/or translation products of the antisense gene ASFMR1.
    Type: Application
    Filed: October 2, 2008
    Publication date: November 4, 2010
    Inventors: Stephen J. Tapscott, Galina N. Filippova, Paula D. Ladd
  • Patent number: 5972643
    Abstract: Polynucleotide molecules encoding CTCF are isolated and purified and sequenced. The CTCF proteins and antibodies thereto can be used to identify mutant CTCFs in methods of diagnosis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 26, 1999
    Assignees: Fred Hutchinson Cancer Research Center, Cancer Research Campaign Technology, Ltd.
    Inventors: Victor L. Lobanenkov, Paul E. Neiman, Elena M. Klenova, Graham H. Goodwin, Galina N. Filippova, Steven J. Collins, Robert H. Nicolas